Neurocrine Bioscience buy Barclays PLC
Start price
23.01.24
/
50%
€129.15
Target price
23.01.25
€137.96
Performance (%)
8.44%
End price
24.01.25
€140.05
Summary
This prediction ended on 24.01.25 with a price of €140.05. The BUY prediction by Barclays_PLC finished with a performance of 8.44%. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Neurocrine Bioscience | 1.665% | 1.665% | 5.957% |
| iShares Core DAX® | -3,81 % | -1,47 % | 6,06 % |
| iShares Nasdaq 100 | 0,49 % | 2,21 % | 12,68 % |
| iShares Nikkei 225® | -4,42 % | 4,97 % | 30,91 % |
| iShares S&P 500 | 0,25 % | 1,23 % | 9,37 % |
Comments by Barclays_PLC for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at Barclays PLC from $145.00 to $150.00. They now have an "overweight" rating on the stock.
Ratings data for NBIX provided by MarketBeat
In the thread Trading Neurocrine Bioscience
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Barclays_PLC for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€129.85
23.12.24
23.12.24
€158.60
23.12.25
23.12.25
-5.81%
24.12.25
24.12.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€109.95
09.09.24
09.09.24
€144.91
09.09.25
09.09.25
10.87%
10.09.25
10.09.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€139.00
02.08.24
02.08.24
€164.74
02.08.25
02.08.25
-20.29%
03.08.25
03.08.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€131.25
02.05.24
02.05.24
€157.54
02.05.25
02.05.25
-26.05%
03.05.25
03.05.25